Enliven Therapeutics shares owned by ProFund Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by ProFund Advisors
from 13F filings
Historical chart of ProFund Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by ProFund Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $157k | 10k | 15.40 |